ARCHIVES

Experts Say Interpretable Results Unlikely In Burzynski’s Antineoplastons Studies

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

NIH director would have broad authority over institute budgets in proposed bill.

July 22, 2005

Sen. Specter Seeks NCI Explanation of Delay in P-4 Breast Cancer Prevention Trial.

May 25, 2007

Advisors OK Planning Grants In Breast Cancer For Cancer Centers

July 9, 1993

Solomon Garb’s Questions/Answers

January 9, 1981

“Leadership Vacuum: At NCI Allows NIH To Look At Reorganization, Varmus Says

November 4, 1994

PDQ Evaluation to Cost NCI More Than Reported

June 29, 1990